相关实验视频
Updated: Jun 15, 2025

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants
Published on: June 9, 2022
在美国常规临床护理中对fostemsavir的免疫和病毒学反应:一个OPERA队列研究
Ricky K Hsu1,2, Laurence Brunet3, Philip C Lackey4
1NYU Langone Health, New York, New York, USA.
福斯特姆萨维尔在病毒性患者中显示出有限的病毒学反应,但在大多数患者中保持了病毒抑制. 观察到免疫学改善,特别是在低CD4计数的严重抑制治疗经验的个体中.
科学领域:
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
背景情况:
- 福斯特姆萨维尔是强度治疗经验丰富 (HTE) 成人的多药耐药HIV-1的附着抑制剂.
- 评估现实世界的有效性对于优化治疗策略至关重要.
研究的目的:
- 评估HTE成年人对fostemsavir的真实免疫和病毒学反应.
- 根据基线病毒载量和CD4 T细胞计数来分层反应.
主要方法:
- 追溯分析了182名HTE成年人开始使用 fostemsavir.
- 评估6个月和12个月CD4T细胞计数和百分比的变化.
- 在6个月和12个月评估病毒载量抑制 (<50副本/毫升).
主要成果:
- 抑制/低CD4组显示CD4数量和百分比中位数增长最大.
- 在大多数被抑制的个体中,病毒载量抑制得到维持.
- 大约一半的病毒性/高CD4患者和三分之一的病毒性/低CD4患者实现了病毒载荷抑制.
结论:
- 福斯特姆萨维尔在病毒性患者中表现出有限的病毒学反应,但在大多数患者中保持了抑制作用.
- 免疫反应各不相同,对低CD4计数的抑制HTE个体有潜在的益处.
更多相关视频
05:46Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
06:14Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
Published on: October 15, 2017
相关概念视频
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Clinical Trials: Overview
Dose-Response Relationship: Potency and Efficacy
Sputum Studies II: Culture and Sensitivity
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...